Geneos Wealth Management Inc. Zynerba Pharmaceuticals, Inc. Transaction History

Geneos Wealth Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Sep 07, 2021	SELL	$7.56 - $15.44 $756 - $1,544	-100 Closed	0 $0
Q2 2019 Sep 07, 2021	BUY	$5.4 - $15.5 $540 - $1,550	100 New	100 $1,000
Q1 2018 Sep 07, 2021	SELL	$8.49 - $13.46 $4,245 - $6,730	-500 Closed	0 $0
Q2 2017 Sep 07, 2021	SELL	N/A	-500 Reduced 50.0%	500 $8,000
Q4 2016 Sep 07, 2021	BUY	N/A	1,000	1,000 $15,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.